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Severe Tubulointerstitial Nephritis from Acute Epstein-Barr Virus Infection
Craig A. Mackaness, DO

Lehigh Valley Health Network, Allentown, PA
Case Presentation

Introduction
A previously healthy, 21-year-old Caucasian
woman presents to our center with a
complaints of fevers recorded as high
o
as 104 F, nausea with vomiting, malaise,
and sore throat. Symptoms had been
progressive over the course of the prior
four weeks. She had been evaluated
by her primary care provider 10 days
prior to hospitalization, and had received
Azithromycin for a diagnosis of left otitis
media.
She denies any difficulties with urination
– no dysuria, flank pain, hematuria, frothy
urine or change in quantity. Oral intake has
been maintained.
The patient is an undergraduate student
at a local urban university. She resides
in a rented row home with seven other
classmates and a cat. She otherwise denies
any other sick contacts, sexual activity
or illicit drugs. Medications include oral
contraceptive pill and a recent Azithromycin
course.
On physical exam she was noted to have
o
a temperature of 40 C and blood pressure
was 107/75. She had evidence of bilateral
pharyngeal erythema with pustular,
exudative lesions. Tender anterior cervical
lymphadenopathy was present.
Cardiopulmonary examination was positive
for a regular tachycardia with diffuse and
scattered bilateral crackles. The edge of the
liver and tip of the spleen were palpable.
The remainder of the examination was
unremarkable.

TABLE 1. Initial Laboratory Data
Hematology

Value

WBC (thou/cmm)

14

Chemistry

Value

Sodium (mEq/L)

136

Neutrophil

41%

Potassium (mEq/L)

3.7

Lymphocyte

5%

BUN (mg/dL)

25

Monocyte

4%

Creatinine (mg/dL)

2.34

Bands

11%

Lactate (mm0l/L)

0.7

Reactive Lymphocytes

39%

CO2 (mEq/L)

22

ALT (U/L)

70

AST (U/L)

70

CK (U/L)

117

Hgb (g/dL)

14.5

Blood Cultures

Negative

Value

Urine
Specific Gravity
pH
Protein (mg/dL)

0.70 (<0.91)

6

EBV VCA IgM

1.68 (<0.91)

0.03

RBC (per hpf)
WBC (per hpf)

Urine Sodium (mEq/L)
Urine Culture

Monospot

Positive (Neg)

ASO

947 (<240)

3 to 5

Mycoplasma IgM

1.27 (<0.91)

6 to 10

Mycoplasma IgG

4.11 (<0.91)

>10

Protein: Creatinine ratio

Value

EBV VCA IgG

300-600

Granular Casts (per lpf)

Serology

1.02

Blood (mg/dL)

2.34
23

HIV

Neg

Leptospirosis

Neg

Resp Viral PCR

Neg

Adenovirus Culture

Neg

Figure 2A.
Shows light microscopic findings. There is a moderately severe
lymphocytic interstitial infiltrate. Eosinophils are minimal. There
are associated patchy foci of active lymphocytic tubulitis, necrotic
tubules with neutrophils and many tubules with granular cell casts,
suggestive of ATN.
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6.

Renal Biopsy Performed
MG/DL

Epstein-Barr Virus (EBV) infection
presents with diverse clinical
manifestations along a broad
spectrum of disease severity.
The classic triad of EBV
infection is fever, pharyngitis,
and lymphadenopathy. Acute
EBV infection may also
manifest as hemolytic anemia,
granulocytopenia, encephalitis,
pericarditis, hepatitis, and other
1
solid organ involvement.
First described in 1889, Acute
renal failure from EBV-infectious
mononucleosis is a rare disease
complication, but subtle
abnormalities in urinalysis, such
as hematuria and proteinuria have
been noted in as many as 15% of
patients.1
Renal involvement of EBV
typically includes a focal interstial
mononuclear infiltrate. Glomerular
involvement is uncommon, though
2
both minimal change lesions as
well as mesangiolysis have been
3
reported.
The diagnosis of EBV involvement in
the kidney has been demonstrated
1,2
using both in situ hybridization as
3
well as PCR assays.
The pathogenesis of EBV induced
renal involvement and its rare
occurrence remain unclear.
T-cell activation, and direct injury
due to EBV have been proposed
4
mechanisms of renal injury.

Discussion

4.

Figure 2B.
Shows direct immunofluorescence using antibodies to CD20, CD3,
CD4, and CD8. The infiltrate is predominately CD4 T-helper cells
(CD4:CD8 ratio around 4:1) However, there is virtually absent CD20
positive B lymphocytes among lymphoid infiltrate.

Acute Epstein Barr virus infection resulting in severe renal impairment is rare and is typically
characterized by acute tubulointerstial disease.
1
Our case contrasts with previously reported cases as the majority of lymphocytes in the
interstitium were CD4+ T-Lymphocytes. Consistent with prior studies, the glomeruli were
unremarkable.
Epstein-Barr encoding region (EBER) in situ hybridization is the methodology of choice for the
detection of the Epstein-Barr virus (EBV) in tissue sections.6
Epstein-Barr Encoding Regions (EBERs) are secreted from EBV-infected cells and are recognized
3
by toll-like receptor (TLR) , leading to induction of type-I Interferons and inflammatory cytokines,
7
and subsequent immune activation.
This case was complicated by evidence of a recent strep infection (elevated ASO titer) but no
evidence of deposits suggestive of post-infectious glomerulonephritis were noted on electron
microscopy. Prior cases of EBV induced renal failure have been preceeded by streptococal
1
infection. In addition, the patient had a recent/concurrent Mycoplasma infection, and it is unclear
1
what role, if any, this had in her renal insufficiency.
Therapy is supportive, with anecdotal evidence supporting parenteral corticosteroids as well as
1
acyclovir to inhibit viral replication.
The patient was treated supportively in regard to her renal manifestations, not requiring renal
replacement therapy. Corticosteroids were initiated for severe tonsilar swelling, at that time her
creatinine had already begun down-trending. She reached a nadir serum creatinine of 0.64mg/dL
in follow up four months following the acute illness.
This case underscores the spectrum of EBV disease beyond the classic manifestations, the
difficulty in identifying the specific pathogenesis of the mechanism of renal dysfunction, and the
heterogeneity of host immunologic responses.
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Figure 1.
Patient’s serum creatinine during hospitalization. Renal biopsy
was performed on hospital day 4. The patient did not require renal
replacement therapy.
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Figure 2C.
Epstein-Barr Encoded RNA (EBER) positive lymphocyte staining in the
interstitium.

© 2014 Lehigh Valley Health Network

I would like to thank Dr. Sharif Ali for the slides and his assistance in this case, and Dr. Sharon Maynard
for her assistance in reviewing the content.

For additional information:
Please contact craigmackaness@gmail.com

